Edition:
United States

McKesson Corp (MCK)

MCK on New York Consolidated

165.07USD
20 Jul 2017
Change (% chg)

$0.22 (+0.13%)
Prev Close
$164.85
Open
$164.66
Day's High
$166.87
Day's Low
$164.61
Volume
1,908,245
Avg. Vol
1,662,024
52-wk High
$199.27
52-wk Low
$114.53

MCK

Chart for MCK

About

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty... (more)

Overall

Beta: 1.12
Market Cap(Mil.): $34,858.57
Shares Outstanding(Mil.): 211.46
Dividend: 0.28
Yield (%): 0.68

Financials

  MCK Industry Sector
P/E (TTM): 6.90 20.77 40.74
EPS (TTM): 23.89 -- --
ROI: 24.09 11.92 52.38
ROE: 51.89 13.42 59.98

Teamsters urge McKesson shareholders to vote against CEO pay

NEW YORK The International Brotherhood of Teamsters urged McKesson Corp's shareholders to vote against the company's executive pay practices and called for it to appoint an independent chairman as the union criticized the drug distributor for its role in the U.S. opioid drug epidemic.

Jul 10 2017

Teamsters urge McKesson shareholders to vote against CEO pay

NEW YORK The International Brotherhood of Teamsters urged McKesson Corp's shareholders to vote against the company's executive pay practices and called for it to appoint an independent chairman as the union criticized the drug distributor for its role in the U.S. opioid drug epidemic.

Jul 10 2017

Teamsters urge McKesson shareholders to vote against CEO pay

NEW YORK, July 10 The International Brotherhood of Teamsters urged McKesson Corp's shareholders to vote against the company's executive pay practices and called for it to appoint an independent chairman as the union criticized the drug distributor for its role in the U.S. opioid drug epidemic.

Jul 10 2017

BRIEF-McKesson reaffirms fiscal 2018 guidance

* FY2018 earnings per share view $12.14, revenue view $205.28 billion -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Jun 28 2017

BRIEF-Mckesson CEO John Hammergren's FY2017 total compensation was $20.1 mln

* CEO John Hammergren's FY 2017 total compensation was $20.1 million versus $23.6 million in fy 2016 - SEC filing

Jun 16 2017

BRIEF-McKesson sets regular quarterly dividend of $0.28/share

* Sets regular quarterly dividend of $0.28/share Source text for Eikon: Further company coverage:

May 24 2017

Drug distributor McKesson's upbeat forecast sends shares soaring

McKesson Corp reported a higher-than-expected quarterly profit and forecast an upbeat full-year earnings, easing concerns about the drug wholesaler's struggles with moderating branded drug price increases and falling prices for generics.

May 18 2017

UPDATE 2-Drug distributor McKesson's upbeat forecast sends shares soaring

May 18 McKesson Corp reported a higher-than-expected quarterly profit and forecast an upbeat full-year earnings, easing concerns about the drug wholesaler's struggles with moderating branded drug price increases and falling prices for generics.

May 18 2017

Drug distributor McKesson's quarterly revenue rises 4.4 pct

May 18 Drug wholesaler McKesson Corp reported a 4.4 percent rise in quarterly revenue, helped by strength in its pharmaceutical distribution and services business.

May 18 2017

BRIEF-Uniprix shareholders approve at 95% Mckesson Canada's bid to acquire Uniprix

* At shareholder meeting, shareholders approved 95% to Mckesson Canada's bid to acquire all outstanding shares of Uniprix Source text for Eikon: Further company coverage:

May 16 2017

Earnings vs. Estimates